Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Continuing its acquisition streak into 2025, Marlborough-based medical device manufacturer Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...

In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...

Boston Scientific (BSX) closed the most recent trading ... As the market closed yesterday, the Medical - Products industry was having an average PEG ratio of 2.1. The Medical - Products industry ...

Shares of Silk Road Medical (SILK) jumped on Tuesday after Boston Scientific (BSX) made a $1.16 billion offer ... Silk Road's platform of products help prevent stroke in patients with carotid ...

Boston Scientific has gained 3% since the start of the year compared to the -4.4% move for the Zacks Medical sector and the 10.2% return for the Zacks Medical - Products industry. The stock has a ...